Drug recall
Contour¿ next GEN Blood Glucose Monitoring System
FDA recall event 92536 · Class II · Ascensia Diabetes Care US, Inc.
Key facts
| Event ID | 92536 |
|---|---|
| Recall numbers | Z-2211-2023 |
| Recalling firm | Ascensia Diabetes Care US, Inc. |
| Product type | Devices |
| Products | Contour¿ next GEN Blood Glucose Monitoring System |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Ascensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the… |
| Initiation date | May 19, 2023 |
| Report date | Jul 26, 2023 |
| City | Valhalla |
| State | NY |
| Country | United States |
| FEI number | 1810909 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: